- Home
- FND vs CORT Comparison
FND vs CORT Comparison
Compare FND & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FND
- CORT
- Stock Information
- Founded
- FND 2000
- CORT 1998
- Country
- FND United States
- CORT United States
- Employees
- FND N/A
- CORT N/A
- Industry
- FND RETAIL: Building Materials
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- FND Consumer Discretionary
- CORT Health Care
- Exchange
- FND Nasdaq
- CORT Nasdaq
- Market Cap
- FND 8.6B
- CORT 7.6B
- IPO Year
- FND 2017
- CORT N/A
- Fundamental
- Price
- FND $87.20
- CORT $75.18
- Analyst Decision
- FND Hold
- CORT Strong Buy
- Analyst Count
- FND 17
- CORT 4
- Target Price
- FND $91.00
- CORT $139.00
- AVG Volume (30 Days)
- FND 2.2M
- CORT 675.5K
- Earning Date
- FND 10-29-2025
- CORT 10-29-2025
- Dividend Yield
- FND N/A
- CORT N/A
- EPS Growth
- FND N/A
- CORT N/A
- EPS
- FND 1.94
- CORT 1.11
- Revenue
- FND $4,600,232,000.00
- CORT $716,080,000.00
- Revenue This Year
- FND $6.49
- CORT $30.62
- Revenue Next Year
- FND $8.64
- CORT $37.68
- P/E Ratio
- FND $44.97
- CORT $67.23
- Revenue Growth
- FND 4.88
- CORT 25.71
- 52 Week Low
- FND $66.01
- CORT $38.68
- 52 Week High
- FND $124.68
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- FND 54.30
- CORT 60.68
- Support Level
- FND $88.07
- CORT $69.03
- Resistance Level
- FND $88.73
- CORT $74.79
- Average True Range (ATR)
- FND 2.90
- CORT 2.69
- MACD
- FND 0.39
- CORT 0.32
- Stochastic Oscillator
- FND 64.17
- CORT 95.68
About FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.